Literature DB >> 11556541

Cathepsins are upregulated by IFN-gamma/STAT1 in human muscle culture: a possible active factor in dermatomyositis.

E Gallardo1, I de Andrés, I Illa.   

Abstract

The aim of this work was to study which genes upregulated by the IFN-gamma/STAT1 system in human muscle might be involved in the process of muscle fiber atrophy in dermatomyositis (DM). These proteins included proteases (cathepsins B and L, calpain), proteins implicated in apoptosis and cell cycle (Bcl-x(l), Fas, p21), structural proteins (beta-actin, utrophin, desmin), and other proteins whose expression is known to be modified by IFN-gamma (neural cell adhesion molecule (N-CAM), major histocompatibility complex-I (MHC-I)). We performed immunocytochemistry, Western blot, and semiquantitative reverse transcriptase-polymerase chain reaction using human muscle cultures. We found upregulation of cathepsins B and L, bcl-x(l) and p21 while N-CAM, calpain, utrophin, desmin, beta-actin and Fas remained at basal levels. Immunohistochemistry on frozen sections from biopsies of patients with different muscle diseases showed upregulation of cathepsin L and calpain in perifascicular muscle fibers in DM. In view of these results, the increased expression of cathepsins L and B after IFN-gamma stimulation in muscle cultures and its inhibition using fludarabine, a STAT1 blocker, further support our previous studies and suggest that the increased expression of cathepsins detected in perifascicular muscle fibers in DM is mediated by IFN-gamma/STAT1 and contributes to their atrophy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11556541     DOI: 10.1093/jnen/60.9.847

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  12 in total

1.  JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.

Authors:  Andrea Bonetto; Tufan Aydogdu; Xiaoling Jin; Zongxiu Zhang; Rui Zhan; Leopold Puzis; Leonidas G Koniaris; Teresa A Zimmers
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-05       Impact factor: 4.310

Review 2.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

Review 3.  Advances in the immunobiology and treatment of inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

4.  Calpain inhibition attenuates intracellular changes in muscle cells in response to extracellular inflammatory stimulation.

Authors:  Kenkichi Nozaki; Arabinda Das; Swapan K Ray; Naren L Banik
Journal:  Exp Neurol       Date:  2010-07-29       Impact factor: 5.330

5.  Role of Calpain in Pathogenesis of Human Disease Processes.

Authors:  Brittany A Potz; M Ruhul Abid; Frank W Sellke
Journal:  J Nat Sci       Date:  2016

6.  Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study.

Authors:  Sergi Clotet-Freixas; Caitriona M McEvoy; Ihor Batruch; Chiara Pastrello; Max Kotlyar; Julie Anh Dung Van; Madhurangi Arambewela; Alex Boshart; Sofia Farkona; Yun Niu; Yanhong Li; Olusegun Famure; Andrea Bozovic; Vathany Kulasingam; Peixuen Chen; S Joseph Kim; Emilie Chan; Sajad Moshkelgosha; Syed Ashiqur Rahman; Jishnu Das; Tereza Martinu; Stephen Juvet; Igor Jurisica; Andrzej Chruscinski; Rohan John; Ana Konvalinka
Journal:  J Am Soc Nephrol       Date:  2020-09-08       Impact factor: 10.121

7.  Calpain inhibition decreases inflammatory protein expression in vessel walls in a model of chronic myocardial ischemia.

Authors:  Brittany A Potz; Ashraf A Sabe; Nassrene Y Elmadhun; Sharif A Sabe; Benedikt J V Braun; Richard T Clements; Anny Usheva; Frank W Sellke
Journal:  Surgery       Date:  2016-12-23       Impact factor: 3.982

Review 8.  Targeted immunotherapy trials for idiopathic inflammatory myopathies.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

9.  Epigenetic regulation of cathepsin L expression in chronic myeloid leukaemia.

Authors:  Misti Samaiya; Sameer Bakhshi; Abhay A Shukla; Lalit Kumar; Shyam S Chauhan
Journal:  J Cell Mol Med       Date:  2011-10       Impact factor: 5.310

10.  Musculoskeletal Consequences of COVID-19.

Authors:  Nathaniel P Disser; Andrea J De Micheli; Martin M Schonk; Maxwell A Konnaris; Alexander N Piacentini; Daniel L Edon; Brett G Toresdahl; Scott A Rodeo; Ellen K Casey; Christopher L Mendias
Journal:  J Bone Joint Surg Am       Date:  2020-07-15       Impact factor: 6.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.